| Identification | Back Directory | [Name]
ERK2 IN-1 | [CAS]
1093061-47-2 | [Synonyms]
ERK2 IN-1 ERK2 IN1,ERK2 IN 1,ERK-2 IN-1 3-Pyrrolidinecarboxamide, 1-[2-[3,6-dihydro-4-[4-(2-pyrimidinyl)phenyl]-1(2H)-pyridinyl]-2-oxoethyl]-N-[3-(4-fluorophenyl)-1H-indazol-5-yl]-3-(methylthio)-, (3S)- | [Molecular Formula]
C36H34FN7O2S | [MDL Number]
MFCD31813669 | [MOL File]
1093061-47-2.mol | [Molecular Weight]
647.76 |
| Hazard Information | Back Directory | [Uses]
ERK2 IN-1 is a selective ERK2 inhibitor with an IC50 of 7 nM[1]. | [IC 50]
ERK2: 7 nM (IC50) | [References]
[1] Boga SB, Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology. Bioorg Med Chem Lett. 2018 Jun 15;28(11):2029-2034. DOI:10.1016/j.bmcl.2018.04.063 |
|
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|